ERBB2 and breast carcinoma: According to molecular profiling, breast cancer is a complicated disease including various molecular subtypes, namely, luminal A, luminal B, human epidermal growth factor receptor 2 (HER2)-enriched, and triple-negative (Sinha et al., 2013).